MiniMed Group, Inc. Common Stock (MMED) has a market capitalization of approximately $4.6B, trading at
MiniMed Group, Inc. Common Stock's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
MiniMed Group, Inc. Common Stock runs a net profit margin of -21.7%, a gross margin of 52.9%, and an operating margin of -9.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
MiniMed Group, Inc. Common Stock reported revenue of
MiniMed Group, Inc. Common Stock does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
MiniMed Group, Inc. Common Stock carries a debt-to-equity ratio of 0.04x and a current ratio of 1.92x, with a market beta of -3.63. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For MiniMed Group, Inc. Common Stock (MMED) the key facts are: market cap $4.6B, revenue
Get MiniMed Group, Inc. Common Stock's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.